Cargando…

N-Acetylcysteine Prevents Hypertension via Regulation of the ADMA-DDAH Pathway in Young Spontaneously Hypertensive Rats

Asymmetric dimethylarginine (ADMA) reduces nitric oxide (NO), thus causing hypertension. ADMA is metabolized by dimethylarginine dimethylaminohydrolase (DDAH), which can be inhibited by oxidative stress. N-Acetylcysteine (NAC), an antioxidant, can facilitate glutathione (GSH) synthesis. We aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fan, Nai-Chia, Tsai, Chih-Min, Hsu, Chien-Ning, Huang, Li-Tung, Tain, You-Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877599/ https://www.ncbi.nlm.nih.gov/pubmed/24455716 http://dx.doi.org/10.1155/2013/696317

Ejemplares similares

Maternal N-Acetylcysteine Therapy Prevents Hypertension in Spontaneously Hypertensive Rat Offspring: Implications of Hydrogen Sulfide-Generating Pathway and Gut Microbiota
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats
por: Zhu, Zhen-Dong, et al.
Publicado: (2019)

Toxic Dimethylarginines: Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA)
por: Tain, You-Lin, et al.
Publicado: (2017)

Sequence Variation in DDAH1 and DDAH2 Genes Is Strongly and Additively Associated with Serum ADMA Concentrations in Individuals with Type 2 Diabetes
por: Abhary, Sotoodeh, et al.
Publicado: (2010)

Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood
por: Hannemann, Juliane, et al.
Publicado: (2022)

Asymmetric Dimethylarginine (ADMA) in Pediatric Renal Diseases: From Pathophysiological Phenomenon to Clinical Biomarker and Beyond
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Changes in ADMA/DDAH Pathway after Hepatic Ischemia/Reperfusion Injury in Rats: The Role of Bile
por: Ferrigno, Andrea, et al.
Publicado: (2014)

Gasotransmitters for the Therapeutic Prevention of Hypertension and Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Chitosan oligosaccharide ameliorates acute lung injury induced by blast injury through the DDAH1/ADMA pathway
por: Liu, Yun-En, et al.
Publicado: (2018)

Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis
por: Wu, Yizheng, et al.
Publicado: (2023)

Developmental and Early Life Origins of Hypertension: Preventive Aspects of Melatonin
por: Tain, You-Lin, et al.
Publicado: (2022)

Impact of High Salt Independent of Blood Pressure on PRMT/ADMA/DDAH Pathway in the Aorta of Dahl Salt-Sensitive Rats
por: Cao, Yu, et al.
Publicado: (2013)

Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine
por: Greco, Rosaria, et al.
Publicado: (2015)

DDAH1/ADMA Regulates Adiponectin Resistance in Cerebral Ischemia via the ROS/FOXO1/APR1 Pathway
por: Zhao, Yichen, et al.
Publicado: (2022)

Blond and blood juice supplementation in high fat diet fed mice: effect on antioxidant status and DDAH/ADMA pathway
por: Sorrenti, V., et al.
Publicado: (2019)

Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway
por: Zhong, Ying, et al.
Publicado: (2022)

Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice
por: Hannemann, Juliane, et al.
Publicado: (2020)

Amino Acids and Developmental Origins of Hypertension
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Melatonin Therapy Prevents Programmed Hypertension and Nitric Oxide Deficiency in Offspring Exposed to Maternal Caloric Restriction
por: Tain, You-Lin, et al.
Publicado: (2014)

Oxidative Stress-Induced Hypertension of Developmental Origins: Preventive Aspects of Antioxidant Therapy
por: Tain, You-Lin, et al.
Publicado: (2022)

Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
por: Zhong, Ying, et al.
Publicado: (2023)

Maternal High-Fat Diet and Offspring Hypertension
por: Tain, You-Lin, et al.
Publicado: (2022)

Whether AICAR in Pregnancy or Lactation Prevents Hypertension Programmed by High Saturated Fat Diet: A Pilot Study
por: Tsai, Wan-Long, et al.
Publicado: (2020)

Early Origins of Hypertension: Should Prevention Start Before Birth Using Natural Antioxidants?
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Targeting the Renin–Angiotensin–Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Melatonin Prevents Chronic Kidney Disease-Induced Hypertension in Young Rat Treated with Adenine: Implications of Gut Microbiota-Derived Metabolites
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Anti-Hypertensive Property of an NO Nanoparticle in an Adenine-Induced Chronic Kidney Disease Young Rat Model
por: Tain, You-Lin, et al.
Publicado: (2023)

Hydrogen Sulfide in Hypertension and Kidney Disease of Developmental Origins
por: Hsu, Chien-Ning, et al.
Publicado: (2018)

Iodomethylcholine Inhibits Trimethylamine-N-Oxide Production and Averts Maternal Chronic Kidney Disease-Programmed Offspring Hypertension
por: Tain, You-Lin, et al.
Publicado: (2023)

A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling
por: Shahin, Nancy N., et al.
Publicado: (2018)

Dihydromyricetin Attenuates TNF-α-Induced Endothelial Dysfunction through miR-21-Mediated DDAH1/ADMA/NO Signal Pathway
por: Yang, Dafeng, et al.
Publicado: (2018)

Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway
por: Chen, Dong, et al.
Publicado: (2017)

Dietary Supplementation of Caulerpa racemosa Ameliorates Cardiometabolic Syndrome via Regulation of PRMT-1/DDAH/ADMA Pathway and Gut Microbiome in Mice
por: Nurkolis, Fahrul, et al.
Publicado: (2023)

Hypertension of Developmental Origins: Consideration of Gut Microbiome in Animal Models
por: Tain, You-Lin, et al.
Publicado: (2022)

The Double-Edged Sword Effects of Maternal Nutrition in the Developmental Programming of Hypertension
por: Hsu, Chien-Ning, et al.
Publicado: (2018)

Regulation of Nitric Oxide Production in the Developmental Programming of Hypertension and Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2019)

Developmental Programming and Reprogramming of Hypertension and Kidney Disease: Impact of Tryptophan Metabolism
por: Hsu, Chien-Ning, et al.
Publicado: (2020)

Adverse Impact of Environmental Chemicals on Developmental Origins of Kidney Disease and Hypertension
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Animal Models for DOHaD Research: Focus on Hypertension of Developmental Origins
por: Hsu, Chien-Ning, et al.
Publicado: (2021)

Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ba1a10j458tmdc2ae7u4t8sit